[ad_1]
The Executive Director of Recce Pharmaceuticals Ltd. (ASX: RCE), James Graham, told Proactive Investors that the company was about to develop a new clbad of synthetic antibiotics to combat antibiotic resistance.
As fears over superbugs could one day reach pandemic proportions, Graham says that no new clbad of antibiotics has been developed for decades.
Having received some global recognition, Recce has accelerated its regulatory review and has successfully completed animal testing, with future human studies, in Australia.
Source link
